The present invention is directed to peptide analogues of fragment of parathyroid
hormone (PTH) or parathyroid hormone-related protein (PTHrP), a method of using
said analogues alone or in combination with a bisphosphonate or calcitonin to treat
osteoporosis and pharmaceutical compositions comprising said analogues alone or
in combination with a bisphosphonate or calcitonin.
